
Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
LIVE TWEETORIAL FROM NLA23 ON ADVANCES IN MANAGEMENT OF HYPERLIPIDEMIA
1b) Dr. Taub is a clinician/scientist and is a frequent contributor to our #accredited programs. She is the founding director of the Step Family...
HFpEF Treatment Algorithm
1b) [email protected] will be sharing the algorithm he uses to treat #HFpEF based on evidence we have thus far and his anecdotal experience treating patients...
Screening for CKD in Patients with T2D: Microalbuminuria
2) Christos Argyropoulos MD, PhD @ChristosArgyrop is Division Chief, Nephrology @UNMHSC. #CKD is chronic #kidneydisease, #ESKD is end-stage kidney...
The Relationship of Natriuresis with Decongestion & Clinical Outcomes after Diuretic Therapy in Acute Heart Failure
2) Our expert author is Frederik H. Verbrugge @FH_Verbrugge Cardiology & ICU @HeartBrussels @UZBrussel | Research @MayoClinicCV | Deputy Editor...
Surgical Considerations in Management of HCM
1b) Our distinguished faculty is Hartzell Schaff, MD, @HSchaffMD, Cardiovascular Surgeon @MayoClinic, and President, American Association for...
MRAs for potential renoprotection in CKD
1b) [email protected] will be reviewing the mechanism of action #MOA of #mineralocorticoid receptor antagonists #MRAs in potential #renoprotection for...
The Patient Burden of PSVT and a Look at Contemporary and Emerging Abortive Management Options
2a) [email protected] & @md_pollack will be discussing patient #burden of #PSVT & take a look at current & #emerging abortive therapies. We see...
Multidimensional, Serial Risk Assessment in PAH: How, Why, and Then What to Individualize Goal-Directed Therapy
1b) @AlbertaPHdoc from #Edmonton will be discussing Multidimensional, Serial #RiskAssessment in #PAH: How, Why, and Then What to Individualize...
Individualized strategies to risk-stratify, manage, and educate patients with advancing CKD in the setting of T2D
2) This #tweetorial is supported by an unrestricted educational grant from Bayer and is intended for healthcare providers.— cardio-met...
HCM: The General Cardiology Perspective, Part 2
2) Our expert author is again Sergio Kaiser MD PhD FACC FESC 🇧🇷🇮🇱 @pabeda1, cardiologist 🫀, Professor 🎓 of #InternalMedicine, Rio de Janeiro State...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.
Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.
Twitter feed is not available at the moment.